---

Study of fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease

---

Original Article

Author Details : Shilpa A., Krishnaswamy D., Indumati V., Vijay V., Shanthala D.

Volume : 4, Issue : 2, Year : 2017

Article Page : 201-205

Suggest article by email

Get Permission

---

Abstract

Introduction: Liver biopsy and ultrasound are the gold standard methods to assess liver fibrosis in chronic liver disease (CLD). Recently Fibrosis Quotient test (Fibro Q test), AST: ALT Ratio (AAR) & AST: Platelet Ratio Indices (APRI) are the three non-invasive and simple indices proposed for assessing liver fibrosis in CLD.
Objectives of the study: To know the efficacy of the indices- Fibro Q test, AAR, APRI as markers of fibrosis in CLD and to know which among these indices would be a high sensitive marker in estimating fibrosis.
Materials and Method: The study includes 60 subjects, out of which 30 were clinically diagnosed as CLD and were confirmed by abdominal ultrasound (USG) and 30 were age and sex matched healthy controls. Fasting blood sample was collected; and AST, ALT, prothrombin time and platelet count were analysed. Fibro Q test, AAR & APRI were calculated. Receiver operating characteristic (ROC) curves were constructed to compare the accuracy of these three non-invasive tests in predicting significant fibrosis in patients with CLD.
Results: Fibro Q, AAR, APRI were significantly increased in cases compared to controls. Fibro Q is a better marker than AAR & APRI, in the prediction of significant liver fibrosis.
Conclusion: Fibro Q test, AAR & APRI indices are efficient markers to evaluate liver fibrosis in patients with CLD. Fibro Q, a novel non-invasive test, is a high sensitive marker than AAR & APRI.

Keywords: AAR- Aspartate Amino Transferase – Alanine Amino Transferase Ratio; APRI- Aspartate Amino Transferase- Platelet Ratio Index; CLD- Chronic Liver Disease; Fibro Q test-Fibrosis Quotient test

How to cite : Shilpa A., Krishnaswamy D., Indumati V., Vijay V., Shanthala D., Study of fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease. Int J Clin Biochem Res 2017;4(2):201-205

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.